Jaclyn Sabanovich
Obstetrics & Gynecology · Redding, CANPI 1487124657
Payments from drug & device makers
Across 288 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$556
- Lilly USA, LLC$469
- Novo Nordisk$323
- Amgen$307
- Boehringer Ingelheim$280
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $1,707 |
| AstraZeneca | 10 | $556 |
| Lilly USA, LLC | 23 | $469 |
| Novo Nordisk | 19 | $323 |
| Amgen | 12 | $307 |
| Boehringer Ingelheim | 13 | $280 |
| Daiichi Sankyo Inc. | 14 | $232 |
| Mylan Specialty L.p. | 11 | $228 |
| Pfizer | 9 | $196 |
| GSK | 12 | $196 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $121 |
| Aimmune Therapeutics, Inc. | 5 | $110 |
| Therapeuticsmd, Inc. | 5 | $103 |
| Johnson & Johnson | 4 | $96 |
| Idorsia Pharmaceuticals US Inc | 6 | $87 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Exact Sciences | 5 | $83 |
| Corcept Therapeutics | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Astellas Pharma US Inc | 3 | $60 |
| Viatris Specialty LLC | 2 | $46 |
| Merck | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $40 |
| Vertex | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Bayer | 2 | $27 |
| C2n Diagnostics, LLC | 1 | $24 |
| Edwards Lifesciences | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Abbott | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $18 |
| Neurelis, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,997 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $20,009 |
| Estradiol | 90 | $12,142 |
| ImvexxyEstradiol | 20 | $4,224 |
| Clindamycin Phosphate | 13 | $1,279 |
| ValacyclovirValacyclovir Hcl | 16 | $811 |
| Levothyroxine Sodium | 21 | $615 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $557 |
| Oxybutynin Chloride | 37 | $352 |
| Amlodipine Besylate | 11 | $174 |
| Cephalexin | 39 | $113 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $97 |
| Fluconazole | 22 | $94 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $60 | $20,00916 claims |
| Therapeuticsmd, Inc.Imvexxy | $103 | $4,22420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Other obstetrics & gynecology in Redding
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.